Notice: This company has been marked as potentially delisted and may not be actively trading. Kindred Biosciences (KIN) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Why Silicon Valley falls prey to ‘charisma distortion,’ according to investor and Google X founding member Tom ChiAugust 19, 2024 | msn.comWillow Smith announces the new release date of her first book “Black Shields Maiden”April 23, 2024 | msn.comTory party donor Frank Hester to be investigated for 'racist comments' by West Yorkshire PoliceMarch 22, 2024 | mirror.co.ukKindred Hospital East GreensboroFebruary 23, 2024 | health.usnews.comJapan's Sony terminates $10 bln Zee India mergerJanuary 22, 2024 | reuters.comEuropean Shares Edge Higher With ECB Meeting In The SpotlightJanuary 22, 2024 | markets.businessinsider.comEarnings Optimism May Contribute To Continued Strength On Wall StreetJanuary 22, 2024 | markets.businessinsider.comHonoree: Nanxi LiuDecember 17, 2023 | latimes.comGlobal Companion Animal Pharmaceuticals Market Size To Worth USD 27.16 Billion by 2032 | CAGR of 5.7%November 8, 2023 | finance.yahoo.comKindred Hospital-DaytonOctober 7, 2023 | health.usnews.comBluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice President, head of business developmentSeptember 21, 2023 | tmcnet.comHow a small Peninsula company plans to take a big bite out of the pet drug marketAugust 17, 2023 | bizjournals.comPet Cancer Therapeutics Global Market Report 2023June 11, 2023 | es-us.finanzas.yahoo.comOral COVID-19 Vaccine Market 2023 Expected Highest Growth and Precise Outlook | Pfizer, CanSino Biologics, Kindred BiosciencesMay 11, 2023 | marketwatch.comPet Medication Market Size and Forecast to 2031May 5, 2023 | marketwatch.comKindred Hospital-New Jersey Morris CountyMay 5, 2023 | health.usnews.comVeterinary Dermatology Drugs Global Market Report 2023April 26, 2023 | uk.finance.yahoo.comKindred Hospital Chicago-NorthlakeApril 25, 2023 | health.usnews.comKindred High SchoolApril 19, 2023 | usnews.comKindred Bio CEO: Expect 3 Dynamic Dog Drugs by 2015April 19, 2023 | thestreet.comKindred review – a reductive, hollow view of Black traumaMarch 31, 2023 | theguardian.comCanine Atopic Dermatitis Market Share and Forecast till 2031March 30, 2023 | marketwatch.comKindred Hospital-OntarioMarch 28, 2023 | health.usnews.comCompanion Animal Pharmaceuticals Market worth $19.6 billion | MarketsandMarketsMarch 22, 2023 | marketwatch.comThe Pet Medication study examines a number of direct and indirect factors that could affect the supply and demand dynamics in this marketMarch 7, 2023 | marketwatch.comHow De La Soul's 3 Feet High and Rising broadened the possibilities of hip hopMarch 6, 2023 | msn.comPet Medication Market 2023 | Global Industry Report Forecast 2029March 3, 2023 | marketwatch.comCanine Atopic Dermatitis Market Growth Insights 2023: Latest Opportunities and Key Companies Profile Analysis By 2028February 10, 2023 | marketwatch.comKate Moss casts Willow star Ellie Bamber to play her in Moss & Freud biopicFebruary 4, 2023 | yahoo.comKindred Cancelled at FXFebruary 2, 2023 | msn.comAnimal Health Market to be Worth $92.8 Billion by 2030: Million InsightsJanuary 17, 2023 | finanznachrichten.de‘Kindred’ creator on adapting sci-fi writer Octavia E. Butler’s novelJanuary 14, 2023 | washingtonpost.comCanine Atopic Dermatitis Market High Growth Opportunities 2023 | CAGR Status, Industry Changing Dynamics, and Size Forecast to 2027January 4, 2023 | marketwatch.comElanco's Tangible Equity Units: Living With The Worst CaseDecember 13, 2022 | seekingalpha.comCanine Atopic Dermatitis Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM IntelligenceNovember 8, 2022 | benzinga.comTCW Special Purpose Acquisition Corp. Appoints Nanxi Liu to Board of DirectorsOctober 24, 2022 | finance.yahoo.comKindreds' milkbread café opens in iconic former Dairy Queen spot in Plaza MidwoodOctober 12, 2022 | bizjournals.comGuest opinion: It's up to us to adapt to those living with 'brain change'September 12, 2022 | finance.yahoo.comThe Global Veterinary Pharmaceuticals Market grew USD 64.19 billion by 2027, at a CAGR of 14.21%.August 30, 2022 | nz.finance.yahoo.comAnnouncing the agenda for TechCrunch Disrupt 2022August 25, 2022 | techcrunch.comCanine Atopic Dermatitis Market Size is projected to reach USD 5.69 Billion by 2030, growing at a CAGR of 16.5%: Straits ResearchAugust 5, 2022 | finance.yahoo.comLollapalooza Day 3 reviews: Willow shows she’s ready for rock operaJuly 31, 2022 | chicago.suntimes.comPet Medication Market Share, Growth Outlook 2022 Dynamics, SWOT Analysis, CAGR Status, Industry Developments and Demand Forecast to 2027July 10, 2022 | marketwatch.comLuvvie Ajayi Jones Wrote ‘Rising Troublemaker’ for Her Teenage Self | Kickback with KindredMay 13, 2022 | yahoo.comMemphis People in Business: Feb. 24, 2022February 24, 2022 | msn.comBluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical OfficerFebruary 2, 2022 | finance.yahoo.comObsEva gains after naming chief strategy officerFebruary 1, 2022 | seekingalpha.comObsEva Appoints Katja Buhrer as Chief Strategy OfficerFebruary 1, 2022 | finance.yahoo.comWhy Kindred Biosciences (KIN) Stock Is Plummeting TodayJanuary 12, 2022 | thestreet.comVeterinary Vaccine Market: EU Trade to Surpass Last Year's $1.7BDecember 21, 2021 | au.finance.yahoo.com Get Kindred Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KIN and its competitors with MarketBeat's FREE daily newsletter. Email Address Forced out of retirement by these trades (Ad)You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changed Make sure to check out Gamma Pockets HERE while it’s still widely available KIN Media Mentions By Week KIN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KIN News Sentiment▼0.000.60▲Average Medical News Sentiment KIN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KIN Articles This Week▼00▲KIN Articles Average Week Get Kindred Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KIN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Evotec News Indivior News Schrödinger News Arcutis Biotherapeutics News Nurix Therapeutics News Arcus Biosciences News Kiniksa Pharmaceuticals News Ocular Therapeutix News Maravai LifeSciences News Aurinia Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KIN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredThis is the worst sign for the U.S. stock market in 50 yearsThe Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts no...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this ...Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kindred Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kindred Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KIN Stock Alerts